Keros Therapeutics, Inc. <KROS.O>: Wells Fargo cuts target price to $18 from $20
KROS•Related News
Nuvation Bio to present subgroup analyses from TRUST-I, TRUST-II taletrectinib studies in ROS1+ NSCLC at WCLC 2026
NUVB•
CoreCivic wins 5-year ICE contract to reopen 1,600-bed Prairie Correctional Facility in Minnesota
CXW•
Snap: Bofa Global Research cuts price objective to $7.00 from $8.00
SNAP•
Sysco FY26 Q4 EPS rises 4.5% to $1.15; sales increase 4.7% to $22.1 billion
SYY•
Millrose Properties Q2 net income rises
MRP•